The prevalence of Api m 10 sensitization and the modification of immunotherapy in bee venom allergy
Open Access
- 1 January 2021
- journal article
- letter
- Published by Termedia Sp. z.o.o. in Advances in Dermatology and Allergology
- Vol. 38 (4) , 699-700
Abstract
It is estimated that 56–94% of the adult population have been stung by a hymenopterous insect at least once in their lifetime, with one third of these cases being stung by a bee [1]. The prevalence of systemic reactions in the adult general population is 0.3–8.9% in Europe [2]. In...Keywords
This publication has 8 references indexed in Scilit:
- Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapyJournal of Allergy and Clinical Immunology, 2016
- Component resolution reveals additional major allergens in patients with honeybee venom allergyJournal of Allergy and Clinical Immunology, 2014
- Component‐resolved diagnosis of wasp (yellow jacket) venom allergyClinical & Experimental Allergy, 2012
- Anaphylaxis caused by Hymenoptera stings: from epidemiology to treatmentAllergy, 2011
- Api m 10, a genuine A. mellifera venom allergen, is clinically relevant but underrepresented in therapeutic extractsAllergy, 2011
- Stinging insect hypersensitivity: A practice parameter update 2011Journal of Allergy and Clinical Immunology, 2011
- Flexible approaches in the design of subcutaneous immunotherapy protocols for Hymenoptera venom allergyAnnals of Allergy, Asthma & Immunology, 2006
- Bee venom allergy in beekeepers and their family membersCurrent Opinion in Allergy and Clinical Immunology, 2005